THE SMART TRICK OF PHARMACEUTICAL MANUFACTURING FORMULATIONS THAT NO ONE IS DISCUSSING

These types of carryover should not end in the carryover of degradants or microbial contamination that will adversely alter the proven API impurity profile.Acceptable procedures ought to be in position to detect contamination and establish the course of action to be taken. Methods should be available to find out the effects on the contamination wit